Literature DB >> 19934184

The use of a dermal substitute (integra) to preserve maximal foot length in a diabetic foot wound with bone and tendon exposure following urgent surgical debridement for an acute infection.

Giacomo Clerici1, Maurizio Caminiti, Vincenzo Curci, Antonella Quarantiello, Ezio Faglia.   

Abstract

In this report, the authors present the case of a 62-year-old female patient who was admitted to our hospital with an acute deep foot infection. The patient was taken immediately to the operating room where she underwent surgical debridement to completely remove all infected tissues; at the end of this first surgical step, all 5 metatarsal bones remained exposed dorsally. Once eradication of infection was completed, we had to decide whether to perform a transmetatarsal amputation at proximal levels, which would have allowed healing by first intention but would have left the patient with a smaller foot stump, or amputation at more distal levels followed by coverage of healthy tendon and bone tissues with a dermal regeneration template (Integra, Integra Life Sciences Corporation, Plainsboro, NJ), which would have preserved the foot stump length and allowed better walking. We opted for the second choice, and the use of a dermal template actually enabled our patient to maintain a considerable foot stump length, much longer than would have resulted from an amputation with immediate primary closure.

Entities:  

Mesh:

Year:  2009        PMID: 19934184     DOI: 10.1177/1534734609350553

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  2 in total

1.  Surgical OFF-LOADING of the diabetic foot.

Authors:  Luca Dalla Paola; Anna Carone; Marialuisa Valente; Mariano Palena; Giuseppe Scavone
Journal:  J Clin Orthop Trauma       Date:  2021-01-22

Review 2.  Challenges in the Treatment of Chronic Wounds.

Authors:  Robert G Frykberg; Jaminelli Banks
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-09-01       Impact factor: 4.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.